- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01662427
Nocturnal Parkinson's Disease Symptoms Study Group
August 18, 2013 updated by: Roongroj Bhidayasiri, Chulalongkorn University
To study associate factor of Noctural Parkinson's Disease Symptoms and quality of life in Parkinson's disease patients and caregivers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bangkok
-
Pathumwan, Bangkok, Thailand, 10330
- Roongroj Bhidayasiri
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Parkinson's disease patient and care givers
Description
Inclusion Criteria:
Idiopathic Parkinson's disease patient
Exclusion Criteria:
- Patient with Secondary Parkinsonism eg.Drug-induced Parkinsonism, Vascular Parkinsonism, exposure to toxin, Encephalitis
- Patient with Atypical Parkinsonial Syndromes eg. Parkinson-plus syndrome, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
- Patient with Heredodegenerative parkinsonism eg. Spinocerebellar ataxias, Wilson's disease, Juvenile Huntington's disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Questionniare
|
Questionaire to assess Noctural Parkinson's Disease Symptoms and quality of life
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
To assess Noctural Parkinson's Disease Symptoms
|
Secondary Outcome Measures
Outcome Measure |
---|
To assess quality of life in Parkinson's Disease patient
|
To assess quality of life in caregiver of Parkinson's Disease patient
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (Actual)
August 1, 2013
Study Completion (Actual)
August 1, 2013
Study Registration Dates
First Submitted
August 7, 2012
First Submitted That Met QC Criteria
August 9, 2012
First Posted (Estimate)
August 10, 2012
Study Record Updates
Last Update Posted (Estimate)
August 20, 2013
Last Update Submitted That Met QC Criteria
August 18, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6222012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
Universidade Federal de PernambucoCompletedParkinson's Disease.Brazil
-
University Hospital, GrenobleCompletedParkinson's Disease (Disorder)France
-
Shanghai East HospitalShanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaRecruitingIdiopathic Parkinson's DiseaseChina
-
Beijing Tiantan HospitalRecruitingPD - Parkinson's DiseaseChina
-
AbbVieActive, not recruitingParkinson's Disease (PD)United States, Australia
-
AbbVieCompletedParkinson's Disease (PD)United States, Australia
-
BlueRock TherapeuticsMemorial Sloan Kettering Cancer CenterActive, not recruitingAdvanced Parkinson's DiseaseUnited States, Canada
Clinical Trials on Questionaire to assess Noctural Parkinson's Disease Symptoms
-
Fondation Ophtalmologique Adolphe de RothschildRemedee SACompletedParkinson DiseaseFrance
-
Shandong UniversityRecruitingEsophageal Motility DisordersChina
-
Centre Hospitalier of ChartresActive, not recruitingCritical IllnessFrance
-
Melike Taşdelen BaşCompleted
-
Ain Shams UniversityCompletedParkinson's Disease | Vascular ParkinsonismEgypt
-
University Children's Hospital BaselRecruitingPulmonary DysfunctionSwitzerland
-
Azienda Sanitaria-Universitaria Integrata di UdineRecruitingSubarachnoid Hemorrhage | Therapeutic Drug Monitoring | Intracerebral HemorrhageItaly
-
Hospital Mutua de TerrassaCompletedInflammatory Bowel Diseases | Hepatitis C Virus InfectionSpain
-
University Hospital, ToursRecruitingInfective EndocarditisFrance